Matthew Forsthoefel
Overview
Explore the profile of Matthew Forsthoefel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Pepin A, Forsthoefel M, Burlile J, Collins B, Simeng S, et al.
Cureus
. 2023 Oct;
15(8):e44440.
PMID: 37791195
Background: Androgen deprivation therapy (ADT) causes fatigue and sexual dysfunction. The time to testosterone recovery depends on patient and treatment-specific characteristics. The kinetics of testosterone recovery in men treated with...
2.
Forsthoefel M, Hankins R, Ballew E, Frame C, DeBlois D, Pang D, et al.
Int J Part Ther
. 2022 Jul;
9(1):28-41.
PMID: 35774493
Purpose: Proton beam radiotherapy (PBT) has been used for the definitive treatment of localized prostate cancer with low rates of high-grade toxicity and excellent patient-reported quality-of-life metrics. Technological advances such...
3.
Konig L, Horner-Rieber J, Forsthoefel M, Haering P, Meixner E, Eichkorn T, et al.
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35626013
Background: Proton beam radiotherapy (PBT) offers physical dose advantages that might reduce the risk for secondary malignancies (SM). The aim of the current study is to calculate the risk for...
4.
Repka M, Creswell M, Lischalk J, Carrasquilla M, Forsthoefel M, Lee J, et al.
Front Oncol
. 2022 Apr;
12:860848.
PMID: 35433457
In this review we outline the current evidence for the use of hydrogel rectal spacers in the treatment paradigm for prostate cancer with external beam radiation therapy. We review their...
5.
McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, DeBlois D, et al.
Acta Oncol
. 2021 Feb;
60(5):649-652.
PMID: 33629926
No abstract available.
6.
Carrasquilla M, Creswell M, Pepin A, Wang E, Forsthoefel M, McGunigal M, et al.
Front Oncol
. 2021 Feb;
10:606260.
PMID: 33537236
Lymph node recurrent prostate cancer is a common clinical scenario that is likely to increase significantly with the widespread adoption of novel positron emission tomography (PET) agents. Despite increasing evidence...
7.
Conroy D, Becht K, Forsthoefel M, Pepin A, Lei S, Rashid A, et al.
Front Oncol
. 2021 Jan;
10:607698.
PMID: 33489918
We describe the utilization of SpaceOAR Vue™, a new iodinated rectal spacer, during Robotic Stereotactic Body Radiation Therapy (SBRT) for a Prostate Cancer Patient with a contraindication to Magnetic Resonance...
8.
Wallerius K, Collins S, Forsthoefel M, Kim H
Otol Neurotol
. 2020 Dec;
42(4):e489-e494.
PMID: 33351559
Objective: Explore the risk of radiation-induced neurotoxicity in patients with multiple sclerosis (MS) treated with stereotactic radiosurgery (SRS) and better understand the pathophysiology of radiation-induced injury in the central nervous...
9.
Badiyan S, Kaiser A, Eastman B, Forsthoefel M, Zeng J, Unger K, et al.
Transl Gastroenterol Hepatol
. 2020 Apr;
5:21.
PMID: 32258525
Immunotherapy represents the newest pillar in cancer care. Although there are increasing data showing the efficacy of immunotherapy there is a spectrum of response across unselected populations of cancer patients....